A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
The Department of Health (DOH) on Friday provided free cervical and breast cancer screening to public school teachers of ...
Cancer is a significant public health issue and economic burden, with breast cancer being the most prevalent among women in ...
“This is another key milestone as we expand our reach to the UK following successful approval across Europe for our innovative infertility and cancer detection products.” stated Kathy Lee-Sepsick, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results